» Articles » PMID: 1658550

Utilization of the Inhibitor Protein of Adenosine Cyclic Monophosphate-dependent Protein Kinase, and Peptides Derived from It, As Tools to Study Adenosine Cyclic Monophosphate-mediated Cellular Processes

Overview
Journal Methods Enzymol
Specialty Biochemistry
Date 1991 Jan 1
PMID 1658550
Citations 20
Authors
Affiliations
Soon will be listed here.
Citing Articles

Proteasome limits plasticity-related signaling to the nucleus in the hippocampus.

Vashisht A, Bach S, Fetterhoff D, Morgan J, McGee M, Hegde A Neurosci Lett. 2018; 687:31-36.

PMID: 30219486 PMC: 6231982. DOI: 10.1016/j.neulet.2018.09.017.


Characterization of PKACα enzyme kinetics and inhibition in an HPLC assay with a chromophoric substrate.

Luzi N, Lyons C, Peterson D, Ellis K Anal Biochem. 2017; 532:45-52.

PMID: 28595966 PMC: 5889107. DOI: 10.1016/j.ab.2017.06.001.


Structure-guided design of selective Epac1 and Epac2 agonists.

Schwede F, Bertinetti D, Langerijs C, Hadders M, Wienk H, Ellenbroek J PLoS Biol. 2015; 13(1):e1002038.

PMID: 25603503 PMC: 4300089. DOI: 10.1371/journal.pbio.1002038.


Polo-like kinase 1 as target for cancer therapy.

Weiss L, Efferth T Exp Hematol Oncol. 2012; 1(1):38.

PMID: 23227884 PMC: 3533518. DOI: 10.1186/2162-3619-1-38.


Proteasome inhibition enhances the induction and impairs the maintenance of late-phase long-term potentiation.

Dong C, Upadhya S, Ding L, Smith T, Hegde A Learn Mem. 2008; 15(5):335-47.

PMID: 18441292 PMC: 2364605. DOI: 10.1101/lm.984508.